FIELD: medicine.
SUBSTANCE: group of inventions relates a means for pneumofibrosis prevention and treatment obtained by irradiation of a solution of a polyoxyethylene-polyoxypropylene triblock copolymer with ionizing radiation and hyaluronate endo-β-N-acetylhexosaminidase and a water-soluble inorganic stabilizer addition to the irradiated solution, and representing a clear solution having a specific activity of hyaluronate-endo-β-N-acetylhexosaminidase, with a pH value of 4.0 to 7.5, becoming turbid when thermostating is above 30°C and again becoming clear upon cooling to 20°C. The group of inventions also relates to a method for production of said means.
EFFECT: ionizing effect on the enzyme is excluded.
9 cl, 2 ex, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| DRUG POSSESSING REGENERATIVE ACTIVITY | 2011 |
|
RU2480236C1 |
| AGENT POSSESSING ANTI-INFLAMMATORY AND ANTIFIBROTIC ACTION IN PULMONARY TISSUE, AND CYTOSTATIC ACTION | 2013 |
|
RU2530651C1 |
| METHOD OF TREATING PULMONARY FIBROSIS | 2012 |
|
RU2494470C1 |
| METHOD FOR IMPROVING THERAPEUTIC EFFECTIVENESS IN LUNG TISSUE DISORDERS AFTER ACTION OF CYTOSTATICS | 2012 |
|
RU2497523C1 |
| METHOD OF STIMULATING LIVER STEM CELL DIFFERENTIATION IN VITRO IN TISSUE-SPECIFIC DIRECTION | 2012 |
|
RU2477752C1 |
| AGENT POSSESSING ANTI-INFLAMMATORY AND ANTIFIBROTIC ACTION IN PULMONARY TISSUE, AND CYTOSTATIC ACTION | 2012 |
|
RU2479312C1 |
| AGENT FOR CORRECTING PULMONARY TISSUE DISORDERS UNDER CYTOSTATIC EXPOSURE | 2013 |
|
RU2554776C1 |
| METHOD FOR PRODUCING AND INDUCING TARGETED DIFFERENTIATION OF PULMONARY PLURIPOTENT CELL CULTURE | 2013 |
|
RU2554843C2 |
| BISAMIDE DERIVATIVE OF DICARBOXYLIC ACID AS AGENT STIMULATING TISSUE REGENERATION AND RESTORATION OF REDUCED FUNCTIONS OF TISSUES | 2016 |
|
RU2727142C2 |
| HEPATOPROTECTOR | 2010 |
|
RU2444569C1 |
